Fresenius Medical Care AG & Co KGaA (FMEG.DE)
48.31EUR
1 Aug 2013
€0.73 (+1.52%)
€50.14
€47.58
€48.48
€47.38
933,757
948,417
€59.58
€46.51
About
Overall
| Beta: | 0.20 |
| Market Cap (Mil.): | €14,634.75 |
| Shares Outstanding (Mil.): | 307.55 |
| Dividend: | 0.75 |
| Yield (%): | 1.58 |
Financials
| FMEG.DE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 18.08 | 23.67 | 37.76 |
| EPS (TTM): | 2.63 | -- | -- |
| ROI: | 7.21 | 7.47 | 18.76 |
| ROE: | 12.16 | 11.89 | 19.59 |
Fresenius Medical Q2 net income down 9 pct on healthcare cuts
FRANKFURT, July 30 - Second-quarter net income at Fresenius Medical Care, the world's largest dialysis provider, dropped 9 percent to a worse-than-expected $263 million, hurt by austerity measures in the United States, its most important market.
European shares retreat, charts signal more weakness
* Euro STOXX 50 down 0.7 pct, fails to hold above 200-day MA
European shares retreat, charts signal more weakness
LONDON, July 2 - European equities drifted lower in thin volumes on Tuesday, led by Fresenius Medical Care , and failure to hold above an important technical level opened the door to further index weakness in the near term.
Dialysis stocks hit by proposed U.S. reimbursement cuts
- A proposal to slash reimbursements to kidney dialysis centers in the United States drove down shares of Fresenius Medical Care AG and Davita Healthcare Partners Inc, two of the world's leading providers of dialysis services.
RPT-Fitch Affirms Fresenius at 'BB+'; Outlook Revised to Positive
June 17 - (The following statement was released by the rating agency)
CORRECTED-German stocks - Factors to watch on May 20
(In May 20 item, corrects to remove Aixtron from ex-dividend section as the company did not pay a dividend for 2012)
German stocks - Factors to watch on May 20
FRANKFURT, May 20 - The DAX top-30 index looked set to open 0.6 percent higher on Monday, which is a public holiday in Germany, though the Frankfurt stock exchange is open for trading.
FMC to launch first ever share buyback on May 20
FRANKFURT, May 17 - German dialysis provider Fresenius Medical Care will begin its first ever share buyback programme on May 20, acquiring up to 385 million euros ($493.72 million) worth of its own stock.
Fresenius SE eyes small and mid-sized acquisition targets-paper
FRANKFURT, May 11 - German diversified healthcare group Fresenius SE has identified potential takeover targets costing up to 300 million euros ($389 million), Chief Executive Ulf M. Schneider told German weekly paper Euro am Sonntag.
UPDATE 1-Fresenius Medical profit below consensus on U.S. costs
FRANKFURT, April 30 - First-quarter net income at Fresenius Medical Care (FMC), the world's largest dialysis provider, dropped more than expected to $225 million on higher costs in the United States, its most important market.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Finlabo SIM Spa
|
$10.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

